Quick View
| Metric | Current Period | Same Period Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥3.12B | ¥3.04B | +2.4% |
| Operating Income | ¥0.03B | ¥0.09B | −67.3% |
| Ordinary Income | ¥0.02B | ¥0.10B | −81.4% |
| Net Income | ¥0.16B | ¥0.06B | +176.8% |
| ROE (Annualized) | 11.5% | 4.2% | - |
Executive Summary
The quarter saw higher revenue but lower earnings, with the failure to convert sales growth into profit being the key takeaway. Revenue was ¥3.12B (+2.4% year on year), Operating Income was ¥0.03B (-67.3%), and Ordinary Income was ¥0.02B (-81.4%). Net Income rose sharply to ¥0.16B (¥0.06B in the same period of the previous year), but this was attributable to extraordinary income, primarily a ¥0.16B gain on the sale of investment securities, and therefore moved in the opposite direction from the decline in core earning power. The decline in gross margin and increase in SG&A expenses were the primary causes of the decrease in Operating Income.
Factors Affecting Earnings
【Revenue】Revenue increased 2.4% year on year to ¥3.12B. By segment, Chains was the main business, accounting for ¥2.90B (93.0% of total revenue), followed by MetalInjectionMolding at ¥0.19B and RealEstate at ¥0.03B. Progress against the full-year plan of ¥4.05B was 76.9%, slightly above the standard progress rate of 75%.
【Profit and Loss】The cost-of-sales ratio rose to 82.5%, causing the gross margin to decline to 17.5% from 19.1% in the previous year. SG&A expenses increased 5.0% year on year to ¥0.52B, outpacing revenue growth, and the SG&A ratio consequently rose to 16.6%. As a result, Operating Income declined to ¥0.03B (-67.3%), with the Operating Income margin narrowing to 0.9% from 2.9% in the previous year. Ordinary Income also remained at ¥0.02B (-81.4%), due in part to an increase in interest expenses (¥0.02B). Meanwhile, Net Income reached ¥0.16B (+176.8% year on year), supported by ¥0.16B in extraordinary income, including a ¥0.16B gain on the sale of investment securities. However, this was a temporary factor, and the core business should be characterized as experiencing higher revenue but lower earnings.
Segment Analysis
By segment, Chains is the core business, generating revenue of ¥2.90B and Operating Income of ¥0.20B (6.8% margin), and accounting for the majority of company-wide profit. MetalInjectionMolding maintained relatively high profitability, with revenue of ¥0.19B and Operating Income of ¥0.03B (17.5% margin). Although RealEstate is small, with revenue of ¥0.03B, it posted an extremely high Operating Income margin of 60.3%, generating Operating Income of ¥0.02B; its contribution to company-wide performance, however, is limited. The gap between the company-wide Operating Income margin of 0.9% and the 6.8% margin of the main Chains business suggests that company-wide common expenses and head-office costs outside the segments may be weighing on earnings.
Key Financial Metrics
【Profitability】The Operating Income margin was 0.9%, approximately 2.0pt lower than 2.9% in the same period of the previous year, while the gross margin also declined to 17.5%. The Net Income margin was 5.2% (+176.8% year on year), but excluding the ¥0.16B gain on the sale of investment securities, no improvement in the profitability of the core business can be confirmed.【Cash Flow Quality】Comprehensive Income remained at ¥0.03B, substantially below Net Income of ¥0.16B. This was attributable to the deterioration in the valuation difference on other securities, from ¥0.13B in the previous year to ¥0.00B. The gap between Net Income and Comprehensive Income is therefore a point of caution regarding earnings quality.【Investment Efficiency】Annualized ROE was 11.5%, but given the significant contribution of extraordinary income to Net Income and the Operating Income margin of 0.9%, it is difficult to regard this figure as reflecting sustainable earning power. Total asset turnover was 0.838x, indicating a moderate level of asset efficiency.【Financial Soundness】The Equity Ratio improved to 37.9% from 36.2% in the previous year. While leverage reduction is progressing, with long-term borrowings declining 8.2% to ¥0.92B, cash and deposits of ¥0.33B were only 0.32x short-term borrowings of ¥1.06B, indicating limited flexibility in short-term liquidity management.
Cash Flow Analysis
Although a statement of cash flows was not disclosed, funding trends can be assessed from changes in the balance sheet. Cash and deposits declined from ¥0.36B in the previous year to ¥0.33B, while short-term borrowings also declined gradually from ¥1.09B to ¥1.06B. Long-term borrowings decreased 8.2% from ¥1.01B to ¥0.92B, indicating an overall trend toward reducing interest-bearing debt. Manufacturing inventories consisted of raw materials of ¥0.32B, work in process of ¥0.46B, and finished goods of ¥0.20B, totaling ¥0.98B. Work in process accounted for 47.2% of total inventories. This concentration in work in process suggests stagnation in the production process or slower inventory turnover, and working capital may be tying up funds. In addition to accounts receivable of ¥0.68B, the company held electronic receivables of ¥0.65B; managing the collection cycles of these assets will be key to improving funding efficiency.
Earnings Quality
The majority of current-period Net Income of ¥0.16B was generated by ¥0.16B in extraordinary income, primarily the ¥0.16B gain on the sale of investment securities, and does not reflect recurring earning power. Operating Income, which represents the strength of the core business, remained at ¥0.03B, while Ordinary Income was ¥0.02B; both contracted significantly from the previous year. In non-operating income and expenses, a foreign exchange gain of ¥0.01B was recorded, while interest expenses of ¥0.02B accounted for the largest portion of non-operating expenses, indicating a considerable interest burden relative to Operating Income. Comprehensive Income was ¥0.03B, substantially below Net Income, primarily due to the deterioration in the valuation difference on other securities (¥0.13B in the previous year → ¥0.00B in the current period). Given the gap between Net Income and Comprehensive Income and the high dependence on extraordinary income, earnings quality in the current period can be assessed as having deteriorated compared with the previous year.
Earnings Forecast and Guidance
Against the full-year plan, Revenue progress was 76.9%, exceeding the standard progress rate of 75%, and performance remained solid. In contrast, Operating Income progress was 52.7%, while Ordinary Income also remained at a similarly low level, making a meaningful increase in Operating Income in Q4 necessary to achieve the full-year plan. Net Income was ¥0.16B on a cumulative basis against the full-year plan of ¥0.14B, exceeding the plan due to the recognition of extraordinary income. However, this was boosted by gains on asset sales and should be viewed separately from the degree of achievement of the plan on a core-business basis.
Shareholder Returns
The Q2 dividend was ¥15.00 per share, and the full-year dividend forecast is ¥30.00 per share. The Payout Ratio against cumulative Net Income of ¥0.16B was 13.6%, while the forecast Payout Ratio against the full-year Net Income plan of ¥0.14B was approximately 28.9%; both remained below 60%. However, because cumulative Net Income is heavily dependent on the gain on the sale of investment securities, the sustainability of dividend funding will depend on the recovery of Operating Income. No share repurchases were confirmed, and shareholder returns are evaluated solely on the basis of dividends.
Risk Factors
-
Declining profitability: The gross margin declined to 17.5% from 19.1% in the previous year, while the Operating Income margin narrowed to 0.9% from 2.9%. If rising costs and delays in passing through prices continue, profitability in the core business may deteriorate further.
-
Inventory efficiency and production-process stagnation: Work in process accounted for 47.2% of manufacturing inventories of ¥0.98B, and inventory days had lengthened to 104 days on an annualized basis. Demand fluctuations and bottlenecks in the production process may affect both working capital and profit margins.
-
Interest expense burden and short-term liquidity: Against interest expenses of ¥0.02B, Operating Income was only ¥0.03B, and interest coverage was 1.79x, indicating limited capacity to service interest payments. Cash and deposits of ¥0.33B were only 0.32x short-term borrowings of ¥1.06B, indicating a high degree of dependence on refinancing.
Industry Benchmark (For Reference; Company Research)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income Margin | 0.9% | 8.6% (4.3%–12.7%) | −7.7pt |
| Net Income Margin | 5.2% | 6.4% (2.8%–10.3%) | −1.2pt |
The Operating Income margin is substantially below the industry median, while the Net Income margin is also slightly below the median.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (Year on Year) | 2.4% | 3.3% (-2.1%–8.9%) | −0.9pt |
The Revenue growth rate is slightly below the industry median, indicating that growth is average or somewhat weak within the industry.
※Source: Company research
Key Earnings Takeaways
-
Revenue increased 2.4% year on year, and full-year plan progress was 76.9%, indicating solid performance. However, Operating Income declined sharply by 67.3%, demonstrating a structure in which revenue growth is not translating into profit growth.
-
The increase in Net Income and annualized ROE of 11.5% depend on extraordinary income, primarily the ¥0.16B gain on the sale of investment securities. In assessing the strength of the core business, greater emphasis should be placed on the Operating Income margin of 0.9%.
-
The combination of a 47.2% work-in-process ratio in manufacturing inventories, inventory days of 104 days, and interest coverage of 1.79x indicates a situation requiring monitoring of both production efficiency and funding conditions.
Theoretical Share Price (Reference Value)
| Scenario | Theoretical Share Price |
|---|---|
| bear (Bearish) | ¥998 |
| base (Base) | ¥1,000 |
| bull (Bullish) | ¥1,002 |
| Assumption | Value |
|---|---|
| Book Value per Share (BPS) | ¥1,357 |
| Adjusted Forecast EPS | ¥8.3 |
| Cost of Equity r | 10.77% (10-year Japanese government bond 2.77% + equity risk premium 6.00% + size premium 2.00%) |
| Residual Income Persistence Coefficient ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 29.5% |
| Forecast EPS Confidence Adjustment | ×1.100 (based on progress ahead of the full-year forecast) |
| Implied PBR / PER | 0.74x / 121.1x |
Sensitivity: ¥973–¥1,028 at ±1% cost of equity, and ¥989–¥1,007 at ω±0.1.
Notes:
- Normalized EPS calculated from Ordinary Income and other figures is used to exclude the impact of temporary gains and losses (company forecast EPS is ¥101.7).
- Because cumulative Net Income progress against the full-year forecast is 112%, exceeding the standard rate of 75%, forecast EPS is adjusted upward within a maximum of +10% (because companies ahead of schedule tend to outperform forecasts; adjustments may be excessive for businesses with strong seasonality).
- Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
- Net assets as of the quarter-end are used (there is a timing discrepancy with the full-year forecast).
- Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.
(Model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest-rate reference month: 2026-07 / This is a mechanically calculated value based solely on publicly disclosed data; it is not a forecast of the market share price or a recommendation of any specific investment action, and does not forecast or guarantee future share prices.)
This report is an automatically generated earnings analysis document created by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, and after consulting a professional as necessary.
---End of Report---